Fresenius Biotech GmbH
Biotechnology - Rapperswil-Jona, St. Gallen, Switzerland
Fresenius Biotech GmbH Employees
Fresenius Biotech GmbH Senior Management
Fresenius Biotech GmbH Details
Neovii is a global leader in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology/oncology. Our lead product, Grafalon®, has been used for over 30 years to treat patients and is available in more than 40 countries world wide. It has approval for use in immunosuppressive therapies for prevention of graft- versus- host disease in stem cell transplantation, prevention and treatment of rejection in solid organ transplantation and in treatment of aplastic anemia.
Website:
http://www.neovii.com
Employees:
109
HQ:
(781) 373-3766
Location:
Rapperswil-Jona, St. Gallen, Switzerland
Revenue:
34.5M
Fresenius Biotech GmbH Technologies
Email Providers
Outlook
Load Balancers
Apache
CMS
WordPress.org
Other
Mobile Friendly